SCHEMBL4945651

SCHEMBL4945651

CCCc1ccc(-c2ccc(Br)cc2)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2E1 P05181 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2A6 P11509 2/20 0.39
CYP2B6 P20813 2/20 0.39
PRKCI P41743 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 2/20 0.36
MAPT P10636 2/20 0.36
RECQL P46063 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PAFAH1B2 P68402 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14114232 0.90 CYP2A6 (0.45) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL4949975 0.86 RAB9A (0.38) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL17088431 0.86 RAB9A (0.38) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL13253535 0.81 HTT (0.44) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL4452318 0.81 APP (0.57) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL11014336 0.81 PTPN1 (0.39) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL24040189 0.81 CYP2A6 (0.60) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL4948080 0.80 KCNH2 (0.39) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL18802998 0.80 ALDH1A1 (0.41) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL4950076 0.80 KCNH2 (0.39) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188670-A1 1,4-Dithienylbenzene Derivative NAT. INST. OF ADVANCED INDUSTRIAL SCI. AND TECH. (JP) 2008-08-07 US disclosed
US-20080188670-A1 1,4-Dithienylbenzene Derivative NAT. INST. OF ADVANCED INDUSTRIAL SCI. AND TECH. (JP) 2008-08-07 US disclosed
US-20080188670-A1 1,4-Dithienylbenzene Derivative NAT. INST. OF ADVANCED INDUSTRIAL SCI. AND TECH. (JP) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188670-A1 1,4-Dithienylbenzene Derivative SLC22A4, SLC19A2, SLC22A1 CYP2C9 2167/4885CYP2C19 2262/4885CYP2E1 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.